Planet Labs PBC (PL) Director Raymond John w Sells $99K of Stock

Raymond John W, a director at Planet Labs PBC, sold 6,494 shares valued at approximately $98,893 on October 13, 2026.

Reviewed by automated data checks against the source filing. How we make and check alerts

Raymond John w, Director at Planet Labs PBC ($PL), sold 6,494 shares at an average price of $15.23, worth about $98,893.23, on October 13, 2026. The trade was reported to the SEC in a Form 4 filing and was made under a pre-arranged Rule 10b5-1 trading plan.

Since the trade, $PL is down 10.6% to date (from the $15.16 close on Oct 13, 2026).

Find the original: PL Form 4 filings on SEC EDGAR

PL Planet Labs PBC
$13.56 -33.56% year to date
Daily close · Oct 16, 2026

Key Points

  • Raymond John W sold 6,494 shares of Planet Labs PBC on October 13, 2026, with a transaction value of about $98,893.
  • The stock was trading at $13.45 on the day of publication, down from a previous close of $14.13.
  • Planet Labs PBC has a market cap of about $5.29 billion and analysts have set a mean price target of $31.73.

Get $PL trade alerts by text

We text you when insiders, Congress or big funds trade $PL. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Planet Labs PBC alert may contain errors. Disclosures

Raymond John W, a director at Planet Labs PBC (NYSE: PL), sold 6,494 shares on October 13, 2026. The shares were sold at an average price of $15.23, bringing the total transaction value to about $98,893. This planned sale adds to the recent activity among company insiders, reflecting ongoing adjustments in the company’s leadership stake.

Inside Raymond John W's Trade

Raymond John W's recent sale involved a total of 6,494 shares, which he sold at $15.23 each. This transaction indicates a significant move for a director, potentially affecting perceptions of the company's future. Even though insiders are often seen as bellwethers of company health, their trades can vary for many reasons, including personal financial planning.

Other Institutional Activity in Planet Labs PBC

Several institutional investors are actively managing their stakes in Planet Labs PBC. American Century Companies Inc opened a new position, adding 8,586,223 shares for a total of 14,399,902 shares worth about $192.8 million. In contrast, Blackrock Inc. trimmed its position by 6,982,519 shares, ending with 18,482,539 shares valued at approximately $247.5 million. Vanguard Capital Management LLC increased its holdings by 682,490 shares, now owning 12,869,821 shares worth about $172.3 million.

Planet Labs PBC Stock Down 4.8%

Planet Labs PBC shares closed at $13.45 on the day this article was published, which is significantly lower than its 52-week high of $51.76. The stock has bounced back from its 52-week low of $10.52. This fluctuation could indicate a volatile market, particularly in the aerospace and defense sector where Planet operates.

Recent Earnings

In its latest earnings report, Planet Labs PBC posted revenue of about $378.3 million, with a growth rate of 58.1%. However, the company reported a loss with an EPS of -$1.10 and a net margin of approximately -95.1%. The next earnings release is scheduled for December 9, 2026, which could provide further insights into its financial health.

Insider Buying and Selling at Planet Labs PBC

In addition to Raymond John W's sale, other insiders have also been active. On September 17, 2026, Ashley Fieglein, the President, sold 55,663 shares at an average price of $16.96, totaling about $944,312. Robert H. Schingler, another officer and director, sold 52,240 shares on the same day for a total of approximately $886,225. These transactions reflect a trend of selling among top executives, which can be a factor for investors to consider.

Analysts Set New Price Targets

Analysts have varying views on Planet Labs PBC. On October 9, 2026, Barclays initiated coverage with an Equal-Weight rating and a target of $17.00. Needham maintained a Buy rating with a new target of $40.00, down from $53.00 on September 4, 2026. Overall, analysts remain cautiously optimistic, with a consensus recommendation of "buy" and a mean target price of approximately $31.73.

About Planet Labs PBC

Planet Labs PBC specializes in the design, construction, and launch of satellite constellations. Its mission is to provide high-frequency geospatial data to customers around the world. This trade by Raymond John W may signal adjustments in insider confidence amid the company's ongoing efforts in the aerospace and defense sector.

Bottom Line

Investors will want to keep an eye on Planet Labs PBC as it approaches its next earnings report on December 9, 2026. The recent insider trades reflect ongoing shifts within the company, while analysts continue to monitor its performance. This 13F filing reminds us that such insider trades can provide context to company leadership strategies and market perceptions.

Source: Raymond John w's Form 4 filing on $PL (Oct 13, 2026). Find the original filing: PL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $PL trade alerts by text